A phase II study of halichondrin B analogue eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California Cancer Consortium trial

INTRODUCTION: Eribulin mesylate (E7389) is an analog of halichondrin B with a unique mechanism of microtubule binding. The activity and toxicity of eribulin were assessed in patients with advanced non-small cell lung cancer (NSCLC) previously treated with a taxane. METHODS: An open-label phase II st...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gitlitz, Barbara J, Tsao-Wei, Denice D, Groshen, Susan, Davies, Angela, Koczywas, Marianna, Belani, Chandra P, Argiris, Athanassios, Ramalingam, Suresh, Vokes, Everett E, Edelman, Martin, Hoffman, Philip, Ballas, Marc S, Liu, Stephen V, Gandara, David R
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2012
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3288403/
https://ncbi.nlm.nih.gov/pubmed/22198425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31823f43ca
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia